FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 40 filers reported holding FATE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,972,000 | +26.1% | 202,000 | -21.1% | 0.02% | +23.5% |
| Q4 2017 | $1,564,000 | +54.2% | 256,000 | 0.0% | 0.02% | +41.7% |
| Q3 2017 | $1,014,000 | +25.2% | 256,000 | +2.4% | 0.01% | +20.0% |
| Q2 2017 | $810,000 | -28.8% | 250,000 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $1,138,000 | +81.2% | 250,000 | 0.0% | 0.01% | +75.0% |
| Q4 2016 | $628,000 | -19.5% | 250,000 | 0.0% | 0.01% | -33.3% |
| Q3 2016 | $780,000 | +16.2% | 250,000 | -36.6% | 0.01% | +20.0% |
| Q2 2016 | $671,000 | -21.4% | 394,537 | -16.9% | 0.01% | -28.6% |
| Q1 2016 | $854,000 | +12.8% | 474,537 | +111.3% | 0.01% | 0.0% |
| Q4 2015 | $757,000 | +50.5% | 224,537 | +137.8% | 0.01% | +27.3% |
| Q3 2015 | $503,000 | +110.5% | 94,437 | +155.2% | 0.01% | +120.0% |
| Q2 2015 | $239,000 | – | 37,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |